Negligible Systemic Uptake of Suprafascial Vancomycin Powder Following Instrumented Posterior Spinal Fusion-Preliminary Results From A Randomized Clinical Trial (VANCO Trial).
Ralph T SchärC Marvin JesseMatteo MontalbettiNicole SöllKatharina LutzValentin SteinsiepeMattia BrancaAndreas RaabeStefan ZimmerliPublished in: Neurosurgery (2022)
Suprafascial vancomycin powder in open instrumented spinal fusion surgery is safe and results in negligible systemic uptake. Final results of the VANCO Trial need to be awaited for conclusive data on the efficacy of vancomycin for SSI prevention and its impact on wound healing.